Physician profile
Deeba Chaudri
NPI 1487722633
$7,283.76
in general payments reported to CMS, 2019-2025
14 companies · $947 in 2025
The $947 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $847 · 2020: $618 · 2021: $944 · 2022: $1,749 · 2023: $1,323 · 2024: $855 · 2025: $947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,883 · Consulting Fee: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,882.79 |
| Consulting Fee | $241.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,151.60 | 2019-2025 | Precision 1, Dailies, Precision 7 |
| Bausch & Lomb Americas INC. | $1,527.68 | 2022-2025 | Infuse, Alden Scleral Zenlens, Miebo |
| Johnson & Johnson Vision Care, INC. | $1,333.23 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,265.27 | 2019-2021 | |
| Coopervision INC. | $262.25 | 2019-2023 | Myday Contact Lens |
| Abb Con-Cise Optical Group LLC | $198.50 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $123.95 | 2024-2025 | Xdemvy |
| Allergan, INC. | $110.44 | 2021-2022 | |
| Abbvie INC. | $106.98 | 2022-2023 | Vuity |
| Kala Pharmaceuticals, INC. | $88.56 | 2021-2022 | |
| Sight Sciences, INC. | $49.22 | 2022 | |
| Shire North American Group INC | $26.05 | 2019 | |
| Novartis Pharmaceuticals Corporation | $22.51 | 2020 | |
| Biotissue Holdings INC. | $17.52 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deeba Chaudri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.